Cargando…
Toward “CO in a Pill”: Silica-Immobilized Organic CO Prodrugs for Studying the Feasibility of Systemic Delivery of CO via In Situ Gastrointestinal CO Release
[Image: see text] Carbon monoxide (CO), an endogenous signaling molecule, is known to exert a range of pharmacological effects, including anti-inflammation, organ protection, and antimetastasis in various animal models. We have previously shown the ability of organic prodrugs to deliver CO systemica...
Autores principales: | Yang, Xiaoxiao, Tripathi, Ravi, Wang, Minjia, Lu, Wen, Anifowose, Abiodun, Tan, Chalet, Wang, Binghe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997063/ https://www.ncbi.nlm.nih.gov/pubmed/36802675 http://dx.doi.org/10.1021/acs.molpharmaceut.2c01104 |
Ejemplares similares
-
Upregulation of p53 through induction of MDM2 degradation: improved potency through the introduction of an alkylketone sidechain on the anthraquinone core
por: Tripathi, Ravi, et al.
Publicado: (2022) -
Sensing a CO-Releasing
Molecule (CORM) Does Not Equate
to Sensing CO: The Case of DPHP and CORM-3
por: Liu, Dongning, et al.
Publicado: (2023) -
Upjohn Pill and Granule Co.
Publicado: (1889) -
Adapting decarbonylation chemistry for the development of prodrugs capable of in vivo delivery of carbon monoxide utilizing sweeteners as carrier molecules
por: De La Cruz, Ladie Kimberly, et al.
Publicado: (2021) -
Organic carbon monoxide prodrug, BW-CO-111, in protection against chemically-induced gastric mucosal damage
por: Bakalarz, Dominik, et al.
Publicado: (2021)